Oligonucleotide Synthesis Market by Product (Primer, Probe, Linker, Adaptor, Custom, Reagent, Equipment), Application (PCR, DNA, RNAi, Research, Therapeutic), End User (Academic, Pharmaceutical, Biotechnology) - Global Forecast to 2024

  • Report ID:MRHC - 104252
  • Pages: 185
  • Apr 2019
  • Formats*: PDF
  • Category: Healthcare

1. Introduction
    1.1. Market Ecosystem
    1.2. Currency & Limitation
           1.2.1. Currency
           1.2.2. Limitations
    1.3. Key Stakeholders

2. Research Methodology
    2.1. Research Pocesss
           2.1.1. Secondary Research
           2.1.2. Primary Research
           2.1.3. Market Size Estimation

3. Executive Summary

4. Market Insights

    4.1. Introduction
    4.2. Market Dynamics
           4.2.1. Drivers
                     4.2.1.1. Growing Adoption of Synthesized Oligonucleotides in Diagnostics and
                                  Clinical Applications
                     4.2.1.2. Rising R&D Expenditure and Government Investment in Pharmaceutical
                                  and Biotechnology Companies
                     4.2.1.3. Plummeting Cost of Sequencing
                     4.2.1.4. Increasing Public-Private Spending on Genomics
                     4.2.1.5. Rising Venture Capital Investments/Funding
           4.2.2. Restraints
                     4.2.2.1. Lack of Regulations for Therapeutic Oligos
                     4.2.2.2. Price Erosion of Synthesized Oligonucleotides
           4.2.3. Opportunities
                     4.2.3.1. Emerging Asian Markets
                     4.2.3.2. Therapeutic Oligos
           4.2.4. Challenges
                     4.2.4.1. Large-Scale Synthesis of Oligonucleotides
                     4.2.4.2. Delivery of Oligonucleotide Drugs to Specific Targets

5. Oligonucleotide Synthesis Market, by Product
    5.1. Introduction
    5.2. Synthesized Oligonucleotides
           5.2.1. By Product
                     5.2.1.1. Primers
                     5.2.1.2. Probes
                     5.2.1.3. Large-Scale Synthesis Oligonucleotides
                     5.2.1.4. Intermediate-Scale Synthesis Oligonucleotides
                     5.2.1.5. Linkers & Adaptors
           5.2.2. By Type
                     5.2.2.1. Custom Oligonucleotides
                     5.2.2.2. Pre-Designed Oligonucleotides
    5.3. Reagents/Consumables
    5.4. Equipment

6. Oligonucleotide Synthesis Market, by Application
    6.1. Introduction
    6.2. Research
           6.2.1. PCR
           6.2.2. qPCR/RTqPCR
           6.2.3. Sequencing
           6.2.4. Gene Synthesis
           6.2.5. Other Research Applications
    6.3. Diagnostics
    6.4. Therapeutics
           6.4.1. RNAi
           6.4.2. Nucleic Acid Aptamers
           6.4.3. DNA/Antisense Oligonucleotides
           6.4.4. Immunotherapy Applications

7. Oligonucleotide Synthesis Market, by End User
    7.1. Introduction
    7.2. Academic Research Institutes
    7.3. Pharmaceutical and Biotechnology Companies
    7.4. Diagnostic Laboratories
    7.5. Others

8. Oligonucleotide Synthesis Market, by Geography
    8.1. North America
           8.1.1. U.S.
           8.1.2. Canada
    8.2. Europe
           8.2.1. Germany
           8.2.2. France
           8.2.3. U.K.
           8.2.4. Italy
           8.2.5. Spain
           8.2.6. Rest of Europe
    8.3. Asia-Pacific
           8.3.1. Japan
           8.3.2. China
           8.3.3. India
           8.3.4. Rest of Asia-Pacific
    8.4. Rest of the World
           8.4.1. Latin America
           8.4.2. Middle East & Africa

9. Competitive Landscape
    9.1. Competitive Benchmarking
    9.2. Market Share Analysis

10. Company Profiles (Includes Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
      10.1. Danaher Corporation
      10.2. Merck KGaA (Sigma-Aldrich Co. LLC)
      10.3. Eurofins Genomics LLC (Part of Eurofins Scientific SE)
      10.4. Thermo Fisher Scientific, Inc.
      10.5. Agilent Technologies, Inc.
      10.6. GE Healthcare
      10.7. GeneDesign Inc. (Part of Ajinomoto Co., Inc.)
      10.8. Kaneka Eurogentec S.A. (Part of Kaneka Corporation)
      10.9. LGC Biosearch Technologies
      10.10. Bio-synthesis Inc.
      10.11. TriLink Biotechnologies LLC (Part of Maravai Lifesciences)
      10.12. ATDBio Ltd.

11. Appendix
      11.1. Questionnaire
      11.2. Available Customization

List of Tables
Table 1 Oligonucleotide Synthesis Market Drivers: Impact Analysis (2018–2024)
Table 2 Global Oligonucleotide Synthesis Market Restraints: Impact Analysis (2018-2024)
Table 3 Global Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
Table 4 Global Synthesized Oligonucleotides Market Size, by Country, 2017-2024 ($Million)
Table 5 Global Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
Table 6 Global Primers Market Size, by Country, 2017-2024 ($Million)
Table 7 Global Probes Market Size, by Country, 2017-2024 ($Million)
Table 8 Global Intermediate Scale Synthesis Oligonucleotides Market Size, by Country, 2017-2024 ($Million)
Table 9 Global Large Scale Synthesis Oligonucleotides Market Size, by Country, 2017-2024 ($Million)
Table 10 Global Linkers and Adapters Market Size, by Country, 2017-2024 ($Million)
Table 11 Global Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 12 Global Custom Oligonucleotides Market Size, by Country, 2017-2024 ($Million)
Table 13 Global Pre-Designed Oligonucleotides Market Size, by Country, 2017-2024 ($Million)
Table 14 Global Reagents Market Size, by Country, 2017-2024 ($Million)
Table 15 Global Equipment Market Size, by Country, 2017-2024 ($Million)
Table 16 Global Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 17 Global Oligonucleotide Synthesis Market Size for Research, by Country, 2017-2024 ($Million)
Table 18 Global Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 19 Global Oligonucleotide Synthesis Market Size for PCR, by Country, 2017-2024 ($Million)
Table 20 Global Oligonucleotide Synthesis Market Size for qPCR/RTqPCR, by Country, 2017-2024 ($Million)
Table 21 Global Oligonucleotide Synthesis Market Size for Sequencing, by Country, 2017-2024 ($Million)
Table 22 Global Oligonucleotide Synthesis Market Size for Gene Synthesis, by Country, 2017-2024 ($Million)
Table 23 Global Oligonucleotide Synthesis Market Size for Other Research Applications, by Country, 2017-2024 ($Million)
Table 24 Global Oligonucleotide Synthesis Market Size for Diagnostics, by Country, 2017-2024 ($Million)
Table 25 Global Oligonucleotide Synthesis Market Size for Therapeutics, by Country, 2017-2024 ($Million)
Table 26 Global Oligonucleotide Synthesis Market Size for Therapeutic, by Type, 2017-2024 ($Million)
Table 27 Global Oligonucleotide Synthesis Market Size for RNAi, by Country, 2017-2024 ($Million)
Table 28 Global Oligonucleotide Synthesis Market Size for Nucleic Acid Aptamers, by Country, 2017-2024 ($Million)
Table 29 Global Oligonucleotide Synthesis Market Size for Antisense Oligonucleotides, by Country, 2017-2024 ($Million)
Table 30 Global Oligonucleotide Synthesis Market Size for Immunotherapy Applications, by Country, 2017-2024 ($Thousand)
Table 31 Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 32 Global Oligonucleotide Synthesis Market Size for Academic Research Institutes, by Country, 2017-2024 ($Million)
Table 33 Global Oligonucleotides Synthesis Market Size for Pharmaceutical and Biotechnology Companies, by Country, 2017-2024 ($Million)
Table 34 Global Oligonucleotide Synthesis Market Size for Diagnostic Laboratories, by Country, 2017-2024 ($Million)
Table 35 Global Oligonucleotide Synthesis Market Size for Other End Users, by Country, 2017-2024 ($Million)
Table 36 Global Oligonucleotide Synthesis Market Size, by Geography, 2017-2024 ($Million)
Table 37 North America: Oligonucleotide Synthesis Market Size, by Country, 2017-2024 ($Million)
Table 38 North America: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
Table 39 North America: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
Table 40 North America: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 41 North America: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 42 North America: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 43 North America: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 44 North America: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 45 U.S.: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
Table 46 U.S.: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
Table 47 U.S.: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 48 U.S.: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 49 U.S.: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 50 U.S.: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 51 U.S.: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 52 Canada: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
Table 53 Canada: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
Table 54 Canada: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 55 Canada: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 56 Canada: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 57 Canada: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 58 Canada: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 59 Europe: Oligonucleotide Synthesis Market Size, by Country, 2017-2024 ($Million)
Table 60 Europe: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
Table 61 Europe: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
Table 62 Europe: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 63 Europe: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 64 Europe: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 65 Europe: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 66 Europe: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 67 Germany: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
Table 68 Germany: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
Table 69 Germany: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 70 Germany: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 71 Germany: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 72 Germany: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 73 Germany: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 74 France: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
Table 75 France: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
Table 76 France: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 77 France: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 78 France: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 79 France: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 80 France: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 81 U.K.: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
Table 82 U.K.: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
Table 83 U.K.: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 84 U.K.: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 85 U.K.: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 86 U.K.: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 87 U.K.: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 88 Italy: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
Table 89 Italy: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
Table 90 Italy: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 91 Italy: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 92 Italy: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 93 Italy: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 94 Italy: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 95 Spain: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
Table 96 Spain: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
Table 97 Spain: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 98 Spain: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 99 Spain: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 100 Spain: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 101 Spain: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 102 RoE: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
Table 103 RoE: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
Table 104 RoE: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 105 RoE: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 106 RoE: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 107 RoE: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 108 RoE: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 109 APAC: Oligonucleotide Synthesis Market Size, by Country, 2017-2024 ($Million)
Table 110 APAC: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
Table 111 APAC: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
Table 112 APAC: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 113 APAC: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 114 APAC: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 115 APAC: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 116 APAC: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 117 China: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
Table 118 China: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
Table 119 China: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 120 China: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 121 China: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 122 China: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 123 China: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 124 Japan: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
Table 125 Japan: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
Table 126 Japan: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 127 Japan: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 128 Japan: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 129 Japan: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 130 Japan: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 131 India: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
Table 132 India: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
Table 133 India: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 134 India: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 135 India: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 136 India: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 137 India: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 138 RoAPAC: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
Table 139 RoAPAC: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
Table 140 RoAPAC: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 141 RoAPAC: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 142 APAC: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 143 RoAPAC: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 144 RoAPAC: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 145 RoW: Oligonucleotide Synthesis Market Size, by Region, 2017-2024 ($Million)
Table 146 RoW: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
Table 147 RoW: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
Table 148 RoW: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 149 RoW: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 150 RoW: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 151 RoW: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 152 RoW: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 153 Latin America: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
Table 154 Latin America: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
Table 155 Latin America: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 156 Latin America: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 157 Latin America: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 158 Latin America: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 159 Latin America: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 160 Middle East & Africa: Oligonucleotide Synthesis Market Size, by Product, 2017-2024 ($Million)
Table 161 Middle East & Africa: Synthesized Oligonucleotides Market Size, by Product, 2017-2024 ($Million)
Table 162 Middle East & Africa: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 163 Middle East & Africa: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 164 Middle East & Africa: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 165 Middle East & Africa: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 166 Middle East & Africa: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 167 Number of Developments by the Major Players during 2015-2018
Table 168 Key Products: Synthesized Oligonucleotides

List of Figures
Figure 1 Research Process
Figure 2 Key Executives Interviewed
Figure 3 Primary Research Techniques
Figure 4 Key Opportunities
Figure 5 Oligonucleotide Synthesis Market, by Product
Figure 6 Oligonucleotide Synthesis Market, by Application
Figure 7 Oligonucleotide Synthesis Market, by End User
Figure 8 Oligonucleotide Synthesis Market, by Region
Figure 9 Market Dynamics
Figure 10 Share of Medical and Health R&D Expenditure of U.S., by Type of Organization: 2015
Figure 11 Global Oligonucleotide Synthesis Market Size, by Product, 2019-2024 ($Million)
Figure 12 Global Synthesized Oligonucleotides Market Size, by Product, 2019-2024 ($Million)
Figure 13 Global Synthesized Oligonucleotides Market Size, by Type, 2019-2024 ($Million)
Figure 14 Global Oligonucleotide Synthesis Market Size, by Application, 2019-2024 ($Million)
Figure 15 Global Oligonucleotide Synthesis Market Size, by End User, 2019-2024 ($Million)
Figure 16 Pharmaceutical R&D Spending, 2011-2017
Figure 17 Global Oligonucleotide Synthesis Market Size, by Geography, 2019-2024 ($Million)
Figure 18 North America: Oligonucleotide Synthesis Market Size, by Country, 2019-2024 ($Million)
Figure 19 Number of People with Chronic Diseases in America: 2005-2030 (Million)
Figure 20 Number of People Aged 60 Years & Above in Europe, in 2017 Vs 2050 (In Million)
Figure 21 Europe: Oligonucleotide Synthesis Market Size, by Country, 2019-2024 ($Million)
Figure 22 Number of Biotech Companies With Business Segments, 2017
Figure 23 Spain: Proportion of Overweight Population (In %), 2000-2020
Figure 24 Spain: Life Expectancy Compared To European Union, 2000-2015
Figure 25 Proportion of Elderly Population in Poland, 2000-2030 (%)
Figure 26 APAC: Oligonucleotide Synthesis Market Size, by Country, 2019-2024 ($Million)
Figure 27 Share of Non-Communicable Diseases in Total Death in China, 2005-2020 (%)
Figure 28 Japan: % of Population Aged 65 Years & Above, 1950-2050 (%)
Figure 29 RoW: Oligonucleotide Synthesis Market Size, by Country, 2019-2024 ($Million)
Figure 30 Growth Strategies Adopted by the Key Players between 2015 and 2018
Figure 31 Oligonucleotide Synthesis Market: Competitive Benchmarking
Figure 32 Danaher Corporation: Financial Overview-2015-2017
Figure 33 Merck KGaA: Financial Overview-2015-2017
Figure 34 Eurofins Scientific: Financial Overview-2016-2018
Figure 35 Thermo Fisher Scientific Inc.: Financial Overview-2015-2017
Figure 36 Agilent Technologies, Inc.: Financial Overview-2015-2017
Figure 37 GE Healthcare: Financial Overview-2015-2017
Figure 38 Ajinomoto Co., Inc.: Financial Overview-2016-2018
Figure 39 Kaneka Corporation: Financial Overview-2016-2018

The global oligonucleotide synthesis market is expected to grow at a CAGR 10.5% from 2019 to 2024 to reach $2.9 billion by 2024. The global oligonucleotide synthesis market is highly competitive and provides robust growth opportunities for biotechnology companies. The growth of this market is mainly attributed to the growing adoption of synthesized oligonucleotides in diagnostic and clinical applications, rising R&D expenditure and government investment in pharmaceutical and biotechnology companies, plummeting cost of sequencing, increasing public & private spending on genomics, and rising venture capital investments/funding. In recent years, this market has witnessed significant rise in acquisition of various small-scale oligonucleotide synthesis companies by major key players to broaden their product & service offerings and expand their presence in oligonucleotide synthesis market.

Plummeting cost of sequencing to fuel the growth of global oligonucleotide synthesis market

The recent advances in the field of genomics research over the past few years have led to substantial reduction in the cost of genome sequencing. The NGS technology has reduced the cost and increased the speed of DNA sequencing significantly. According to statistics from the National Human Genome Research Institute (NHGRI), the cost of sequencing a human genome has decreased substantially from ~$5 million in 2008 to ~$1000 in 2017. In genomics research field, sequencing is being applied not only to assemble genomes and to investigate the genetic basis of human diseases, but also to understand the diverse nature of reproductive medicine, oncology, and infectious diseases. Thus, the rapidly plummeting cost of sequencing would boost the research activities, thereby fuelling the demand of oligonucleotide synthesis during the forecast period.

Key Findings in the global oligonucleotide synthesis market study:

Synthesized oligonucleotides dominates the oligonucleotide synthesis market, by product

Synthesized oligonucleotides accounted for the largest share over reagents/consumables and equipment of the global market in 2018, owing to the growing use of synthesized oligonucleotides in various biological research experiments to study critical diseases.

Research segment dominates the global oligonucleotide synthesis market, by application

In 2018, research segment commanded the largest share as compared to diagnostic and therapeutic applications. However, use of oligonucleotides for diagnostic applications is likely to grow at the highest CAGR during the forecast period. This is mainly due to developing applications of molecular diagnostics (MDx) and genetic testing.

Diagnostic laboratories to register the fastest CAGR

On the basis of end user, oligonucleotide synthesis market is segmented into academic research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and other end users. Academic research institutes commanded the largest share of the global oligonucleotide synthesis market in 2018. However, diagnostic laboratories are expected to register the highest CAGR during the forecast period owing to rising application of oligonucleotide in diagnostic applications.

North America dominates the global oligonucleotide synthesis market

In 2018, North America dominated the global oligonucleotide synthesis market, followed by Europe. However, Asia-Pacific is expected to grow at the highest CAGR during the forecast period. Factors supporting growth for this region include the growing availability of synthesized oligonucleotides, strong presence of pharma & biotech companies, growing outsourcing to CROs, and increase in R&D funding and activities in the APAC region.

Key Players

The key players in the global oligonucleotide synthesis market are Integrated DNA Technologies, Inc. (U.S.) (Part of Danaher Corporation), Merck KGaA (Germany), Eurofins Scientific(Luxembourg), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), GE Healthcare (U.S.), GeneDesign, Inc. (Japan) (Part of Ajinomoto Co., Inc.), Kaneka Eurogentec (Belgium) (Part of Kaneka Corporation), LGC Biosearch Technologies (U.S.), Bio-synthesis Inc. (U.S.), TriLink BioTechnologies, LLC (U.S.) (Part of Maravai LifeSciences), and ATDBio Ltd. (U.K.) among others.

Future Outlook

In recent years, interest in oligonucleotide therapeutics has resurged with development of new approaches, clinical applications, advances in delivery, and a deeper biological understanding of these compounds. More recently, the strategy for delivering oligonucleotide therapeutics has changed from non-specific uptake, to targeted delivery. Although there remain some challenges, the development of oligonucleotide therapeutics is extremely promising.

Scope of the Report:

Market By Product

  • Synthesized Oligonucleotides
    • By Product
      • Primers
      • Probes
      • Intermediate-Scale Synthesis Oligonucleotides
      • Large-Scale Synthesis Oligonucleotides
      • Linkers & Adaptors
    • By Type
      • Custom Oligonucleotides
      • Pre-Designed Oligonucleotides
    • Reagents
    • Equipment

Market By Application

  • Research
    • PCR
    • QPCR/RTQPCR
    • Sequencing
    • Gene Synthesis
    • Other Research Applications
  • Diagnostics
  • Therapeutics
    • RNAi
    • Nucleic Acid Aptamers
    • DNA/Antisense Oligonucleotides
    • Immunotherapy Applications

Market By End User

  • Academic Research Institutes
  • Pharmaceutical And Biotechnology Companies
  • Diagnostic Laboratories
  • Others

Market by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Rest of World
    • Latin America
    • Middle East & Africa
Report Name
Full Name
Email
Job Title
Company
Country
Phone Number
--
Your Specific Interest
Captcha Code:
This website is secure and we do not share your personal information with any third party. Privacy Policy
Tags: Healthcare Medical Technologies
Download Free Sample